Sun Pharma, Dr Reddy's, Zydus plan early launch In December 2025, India's largest drug maker, Sun Pharmaceutical Industries, received Drug Controller General of India (DCGI) approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Lower doses are where most patients start
Avoid Blood-Thinning Substances : Instruct patients to avoid blood-thinning supplements like vitamin E and medications like aspirin and ibuprofen before their treatment
The diagnosis of BPI was made by a neurologist
Our guide on why weight gain occurs on tirzepatide covers the most common reasons and solutions
[DOI] [PubMed] [Google Scholar] 20.Sarkar R, Ghunawat S, Narang I, Verma S, Garg VK, Dua R